Hi Jupiter, sorry to hear your wife is suffering.
Cannabis does help with symptoms of UC.
Smoking is one way to relieve symptoms and taking a cannabis oil is another as well as a variety of concentrates.
It's not just the CBD's that help either...
"
Cannabis has been determined to effectively address the symptoms associated with inflammatory bowel disease disease. Two cannabinoids found in cannabis, tetrahydrocannabinol (THC) and cannabidiol (CBD), possess anti-inflammatory effects, offer pain relief, reduce nausea and stimulate appetite. As a result, cannabis use is common among those with inflammatory bowel disease. One study found that 17.6% of inflammatory bowel disease patients use marijuana to treat their symptoms, and although use was also found to be associated with a higher risk of surgery, patients reported an improvement in abdominal pain (83.9%), abdominal cramping (76.8%), joint pain (48.2%), and diarrhea (28.6%) (Storr, et al., 2014)."
Pop22 has a nice write up on making oil
https://www.autoflower.org/threads/pop22s-medicinal-canna-coconut-oil-how-i-make-it.51201/
Eekman has a write up on a real good cbd oil. This oil is not decarbed (not psychoactive) and uses all parts of the plant.
https://www.autoflower.org/threads/intense-cbd-oil-recipe.30960/
Once your wife finds what method she prefers, you won't believe how easy it is to make the medicine.
http://medicalmarijuanainc.com/inflammatory-bowel-disease/
INFLAMMATORY BOWEL DISEASE – MEDICAL MARIJUANA RESEARCH OVERVIEW
October 6, 2015 | admin
The following information is presented for educational purposes only. Medical Marijuana Inc. provides this information to provide an understanding of the potential applications of cannabidiol. Links to third party websites do not constitute an endorsement of these organizations by Medical Marijuana Inc. and none should be inferred.
Inflammatory bowel disease, which caused 51,000 deaths in 2013, is the chronic inflammation of the digestive track. Studies have shown marijuana reduces the pain, nausea and diarrhea associated with the disease and even shows promise as a treatment that encourages remission.
Overview of Inflammatory Bowel Disease
Inflammatory bowel disease (IBD) is chronic inflammation of lining of the digestive track. The two major types of IBD are ulcerative colitis, which affects the innermost lining of the large intestine and rectum, and Crohn’s disease, which can affect different areas of the digestive track and often sees the inflammation spread deep into affected areas. More rare types of IBD’s include collagenous colitis and lymphocytic colitis.
The symptoms associated with IBD vary depending on inflammation severity. The disease causes abdominal pain, rectal bleeding, severe diarrhea, fever, weight loss, fatigue, blood in one’s stool, and malnutrition. The pain caused by IBD can be debilitating.
Heredity and abnormal behavior by the immune system are likely what cause Crohn’s disease. Those who have family members with the disease are more common to acquire it themselves. When the immune system responds to fight off a virus, bacteria, fungi and other microorganisms, at times it can respond abnormally and also attack the harmless cells in the digestive track, which in turn leads to inflammation.
There is no confirmed cure for inflammatory bowel disease. However, treatments significantly reduce the disease’s associated symptoms and in some cases, even bring about remission. Treatment efforts commonly include anti-inflammatory, antibiotic, anti-diarrhea, and pain relief medications. In some cases, a feeding tube may be necessary to allow the digestive track to rest and lower inflammation. Surgery may be employed remove the damaged portion of the digestive track.
Findings: Effects of Cannabis on Inflammatory Bowel Disease
Cannabis has been determined to effectively address the symptoms associated with inflammatory bowel disease disease. Two cannabinoids found in cannabis, tetrahydrocannabinol (THC) and cannabidiol (CBD), possess anti-inflammatory effects, offer pain relief, reduce nausea and stimulate appetite. As a result, cannabis use is common among those with inflammatory bowel disease. One study found that 17.6% of inflammatory bowel disease patients use marijuana to treat their symptoms, and although use was also found to be associated with a higher risk of surgery, patients reported an improvement in abdominal pain (83.9%), abdominal cramping (76.8%), joint pain (48.2%), and diarrhea (28.6%) (Storr, et al., 2014).
The benefits of cannabis help those with inflammatory bowel disease to manage their discomfort and experience a better quality of life. In one study, after three months of being treated with cannabis, inflammatory bowel disease patients reported improvements in their general health perception, social functioning, ability to work, physical pain and depression. These same patients also saw an increase in body weight and body mass index (Lahat, Lang & Ben-Horin, 2012). In another study, individuals with inflammatory bowel disease reported that marijuana was “very helpful” in relieving their abdominal pain, nausea and diarrhea (Ravikoff, et al., 2013). In individuals with Crohn’s disease, cannabis caused a significant improvement in appetite and sleep (Naftali, et al., 2013). Nausea relief as well as reductions in both pain sensation and feelings of unpleasantness was reported after cannabis use in another study (Schicho & Storr, 2014). In addition, using cannabis has also been shown to reduce the need of other medications in patients with Crohn’s disease (Naftali, et al., 2013).
Research also suggests that cannabis may be effective at helping those with inflammatory bowel disease to reach long-term remission. Medical cannabis use has been determined to be associated with an improvement in disease activity (Naftali, Mechulam, Lev & Konikoff, 2014). In one study, cannabis rich in tetrahydrocannabinol (THC) produced significant benefits to 10 or 11 patients with active Crohn’s disease, without side effects, and 5 of those 11 subjects achieved complete remission (Naftali, et al., 2013).
States That Have Approved Medical Marijuana for Inflammatory Bowel Disease
Currently,
Maine,
New Jersey,
New York,
Ohio and
Pennsylvania have approved medical marijuana specifically for the treatment of inflammatory bowel disease.
Other states have approved medical marijuana to treat only specific types of inflammatory bowel diseases, including
Arizona (Crohn’s disease),
Connecticut (Crohn’s disease, ulcerative colitis),
Georgia (Crohn’s disease),
Hawaii (Crohn’s disease),
Illinois (Crohn’s disease),
Maine (Crohn’s disease),
Massachusetts (Crohn’s disease),
Michigan (Crohn’s disease),
Minnesota (Crohn’s disease),
Montana (Crohn’s disease),
New Hampshire (Crohn’s disease),
New Jersey(Crohn’s disease),
New Mexico (Crohn’s disease),
Rhode Island (Crohn’s disease), and
Washington (Crohn’s disease).
A number of other states will consider allowing medical marijuana to be used for the treatment of inflammatory bowel disease with the recommendation from a physician. These states include:
California (any debilitating illness where the medical use of marijuana has been recommended by a physician),
Connecticut (other medical conditions may be approved by the Department of Consumer Protection),
Massachusetts (other conditions as determined in writing by a qualifying patient’s physician),
Nevada (other conditions subject to approval),
Oregon (other conditions subject to approval),
Rhode Island (other conditions subject to approval), and
Washington (any “terminal or debilitating condition”).
In
Washington D.C., any condition can be approved for medical marijuana as long as a DC-licensed physician recommends the treatment.
Fourteen states have approved medical marijuana specifically to treat “chronic pain,” a symptom commonly associated with inflammatory bowel disease. These states include:
Alaska,
Arizona,
California,
Colorado,
Delaware,
Hawaii,
Illinois (Chronic Post-Operative Pain),
Maine,
Maryland,
Michigan,
Montana,
New Mexico,
Oregon, and
Rhode Island. The states of
Nevada,
New Hampshire and
Vermont allow medical marijuana to treat “severe pain.” The state of
Washington has approved cannabis for the treatment of “intractable pain.”
Recent Studies on Cannabis’ Effect on Inflammatory Bowel Disease
- A clinical study showed that cannabis produces significant clinical benefits in patients with Crohn’s disease, including a reduction in pain sensation, nausea relief and reduce the feeling of unpleasantness.
Cannabis finds its way into treatment of Crohn’s disease.
(http://www.ncbi.nlm.nih.gov/pubmed/24356243)
- Three months of inhaled cannabis treatment caused an increase in quality of life measurements, disease activity index and caused gains in weight and body mass index in patients with inflammatory bowel disease.
Impact of cannabis treatment on the quality of life, weight and clinical disease activity in inflammatory bowel disease patients: a pilot prospective study.
(http://www.ncbi.nlm.nih.gov/pubmed/22095142)
References
GBD 2013 Mortality and Causes of Death Collaborators. (2015, January 10). Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013.
Lancet, 385(9963), 117-71.
Inflammatory bowel disease (IBD). (2015, February 18).
Mayo Clinic. Retrieved from
http://www.mayoclinic.org/diseases-...-bowel-disease/basics/definition/con-20034908.
Lahat, A., Lang, A. and Ben-Horin, S. (2012). Impact of cannabis treatment on the quality of life, weight and clinical disease activity in inflammatory bowel disease patients: a pilot prospective study.
Digestion, 85(1), 1-8.
Naftali, T., Bar-Lev Schleider, L., Dotan, I., Lansky, EP., Sklerovsky Benjaminov, F. and Konikoff, FM. (2013, October). Cannabis induces a clinical response in patients with Crohn’s disease: a prospective placebo-controlled study.
Clinical Gastroenterology and Hepatology, 11(10), 1276-1280.
Naftali, T., Mechulam, R., Lev, LB, and Konikoff, FM. (2014). Cannabis for inflammatory bowel disease.
Digestive Diseases, 32(4), 468-74.
Ravikoff Allegretti, J., Courtwright, A., Lucci, M., Korzenik, JR. and Levine, J. (2013, December). Marijuana use patterns among patients with inflammatory bowel disease.
Inflammatory Bowel Diseases,19(13), 2809-14.
Schicho, R. and Storr, M. (2014). Cannabis finds its way into treatment of Crohn’s disease.
Pharmacology, 93(1-2), 1-3.
Storr, M., Devlin, S., Kaplan, G.G., Panaccione, R., and Andrews, C.N. (2014, March). Cannabis use provides symptom relief in patients with inflammatory bowel disease but is associated with worse disease prognosis in patients with Crohn’s disease.
Inflammatory Bowel Diseases, 20(3), 472-80.
- See more at:
http://medicalmarijuanainc.com/inflammatory-bowel-disease/#sthash.oYd0eHUS.dpuf